Top 10 stocks. Once a month. Expert picks, straight to your inbox.See the newsletter
Clover Health logo

Clover Health

CLOV
$4.17
+3%since Benson's first pick

Market price data through July 31, 2026.

Performance

Aug 2021Jul 2026

Benson's first pick
$0$4$8$12Aug 2021Oct 2022Jan 2024May 2025Jul 2026Benson picked · $3.94
Model signal
Buy
What Benson's model currently says about this stock.
Benson rating
3.8 / 5
Benson's overall conviction in this stock right now.
Risk
High risk
How bumpy the ride tends to be with this stock.

Track record

How this pick has done since Benson first called it.

Benson Return
+3%
How much this stock is up since Benson first picked it — measured from the price at the time of that first pick, not from today.
First pick price
~$4
Roughly what one share cost when Benson first picked this stock. This is the starting line for the Benson Return.
Tracking since
October 2024
The month this stock first became a Benson pick.
Tracking duration
21 months
How long Benson has been tracking this pick.

About Clover Health

Clover Health offers Medicare Advantage health insurance plans for seniors, powered by its own software called Clover Assistant that helps doctors spot health problems early. Think of it as a tech-forward insurance company built specifically for people 65 and older.

The case for and against

Both sides of the story, in plain English.

Bull case
  • Profit Pivot

    Clover is on track for its first full year of actual GAAP profits in 2026, with guidance pointing to revenue between 2.81 and 2.92 billion dollars, up about 49 percent. Membership is set to jump roughly 46 percent as more seniors sign up. After years of losses, this is the year the math finally flips in their favor.

  • Sticky Seniors

    More than 95 percent of Clover's existing members renewed their plans, and seasoned members generate over 200 dollars in monthly profit each. That kind of loyalty turns a chaotic insurance business into a predictable cash machine. The longer someone stays, the more profitable they become.

Bear case
  • CFO Shakeup

    Clover just announced its Chief Financial Officer is stepping down at the end of March 2026, with an interim leader stepping in. Even though the company says nothing is wrong and reaffirmed its full year guidance, losing your top finance executive right as you pivot to profitability is the kind of thing that makes investors nervous. Smooth execution is everything from here.

  • Wild Ride

    This stock swings hard, with a beta of 2.45, meaning it moves more than twice as much as the overall market on any given day. Net margins are still negative at about negative 4.45 percent, so the business is not yet consistently profitable. If medical costs spike or new member growth disappoints, the share price can drop fast.

How to read this page

This automated research summary uses Financial Modeling Prep market data through 2026-07-31. Model signals, scores, and risk labels can change and may be incomplete or wrong.

Want Benson to watch CLOV for you?

Get the app to follow every Benson pick live — and let Benson do the research for you.